Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Apydan Extent
- Development stage
- Unknown
- Lead developer
- Desitin Arzneimittel
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
**Apydan Extent** is a brand name for a modified-release (extended-release) oral tablet formulation of the active ingredient **oxcarbazepine**, an antiepileptic drug developed and manufactured by **Desitin Arzneimittel GmbH** primarily for the European market, such as Germany and Switzerland. Oxcarbazepine acts by reducing uncontrolled electrical signal transmission in brain nerve cells through voltage-dependent blockade of sodium channels, thereby stabilizing neuronal membranes and inhibiting seizure spread; it is primarily indicated as adjunctive or monotherapy for partial seizures with or without secondary generalization in adults and children aged 6 years and older.[1][2][3][5][6]
- Brand names
- Apydan Extent
- Other names
- oxcarbazepine sustained releasesustained-release oxcarbazepine
02
Targets
NaV (Voltage-gated sodium channels)
Beyond the preview
Go deeper on Apydan Extent.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Apydan Extent.